艾滋病病毒感染与肠道菌群之间的相互作用关系研究进展
Progress in the Interaction Relationship between HIV Infection and Gut Microbiome
DOI: 10.12677/AMB.2021.104021, PDF,   
作者: 张馨予, 阳伊蕾, 赵乃睿, 李悦绮：温州医科大学第二临床医学院，浙江 温州；赵 威*：温州医科大学第二临床医学院，浙江 温州；温州医科大学基础医学院，浙江 温州
关键词: 肠道菌群；艾滋病；黏膜免疫；肠道菌群易位；Intestinal Microflora； AIDS； Mucosal Immunity； Intestinal Flora Translocation
摘要: HIV的感染与肠道屏障被破坏和微生物产物的移位密切相关。因HIV感染而引起的肠道菌群失调愈发受到关注。目前研究主要致力于理解HIV感染后肠道微生态的变化情况，即肠道微生物组的构成以及它们是如何与黏膜免疫细胞相互作用来引起全身炎症的。本文主要综述了目前研究HIV感染与微生态及其失调的关系和失调与HIV发病机理的内在联系，以便更好地理解微生态相关的免疫激活和驱动全身炎症反应的机制，从而制定不同的治疗方案来改善肠道菌群失调，进而提高HIV感染者的整体健康。
Abstract: HIV infection is closely associated with the disruption of the intestinal barrier and the displacement of microbial products. Intestinal microflora dysregulation caused by HIV infection are gaining attention. The current research is focused on understanding the changes in gut microbiome following HIV infection including the composition of the gut microbiome and how they interact with mucosal immune cells to cause systemic inflammation. This paper reviews the relevance of the present study of the relationship between HIV infection and intestinal microflora dysregulation and the intrinsic link between dysregulation and the pathogenesis of AIDS. The data will gain a better understanding the mechanisms of the microecology-related immune activation and drive systemic inflammatory response. Thus formulate differences treatment options to improve intestinal microbiosis, and then improve the overall health of people infected with HIV.
文章引用：张馨予, 阳伊蕾, 赵乃睿, 李悦绮, 赵威. 艾滋病病毒感染与肠道菌群之间的相互作用关系研究进展[J]. 微生物前沿, 2021, 10(4): 167-174. https://doi.org/10.12677/AMB.2021.104021

参考文献

[1] Sender, R., Fuchs, S. and Milo, R. (2016) Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans. Cell, 164, 337-340. [Google Scholar] [CrossRef] [PubMed]
[2] Nicholson, J.K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., et al. (2012) Host-Gut Microbiota Metabolic Interactions. Science, 336, 1262-1267. [Google Scholar] [CrossRef] [PubMed]
[3] Frank, D.N., Robertson, C.E., Hamm, C.M., Kpadeh, Z., Zhang, T., Chen, H., et al. (2011) Disease Phenotype and Genotype Are Associated with Shifts in Intestinal-Associated Microbiota in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases, 17, 179-184. [Google Scholar] [CrossRef] [PubMed]
[4] Frank, D.N., St Amand, A.L., Feldman, R.A., Boedeker, E.C., Harpaz, N. and Pace, N.R. (2007) Molecular-Phylogenetic Characterization of Microbial Community Imbalances in Human Inflammatory Bowel Diseases. Proceedings of the National Academy of Sciences of the United States of America, 104, 13780-13785. [Google Scholar] [CrossRef] [PubMed]
[5] Li, E., Hamm, C.M., Gulati, A.S., Sartor, R.B., Chen, H., Wu, X., et al. (2012) Inflammatory Bowel Diseases Phenotype, C. difficile and NOD2 Genotype Are Associated with Shifts in Human Ileum Associated Microbial Composition. PLoS ONE, 7, e26284. [Google Scholar] [CrossRef] [PubMed]
[6] Brown, K., DeCoffe, D., Molcan, E. and Gibson, D.L. (2012) Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity and Disease. Nutrients, 4, 1095-1119. [Google Scholar] [CrossRef] [PubMed]
[7] John, G.K. and Mullin, G.E. (2016) The Gut Microbiome and Obesity. Current Oncology Reports, 18, 45. [Google Scholar] [CrossRef] [PubMed]
[8] Alkanani, A.K., Hara, N., Gottlieb, P.A., Ir, D., Robertson, C.E., Wagner, B.D., et al. (2015) Alterations in Intestinal Microbiota Correlate with Susceptibility to Type 1 Diabetes. Diabetes, 64, 3510-3520. [Google Scholar] [CrossRef] [PubMed]
[9] Markle, J.G., Frank, D.N., Mortin-Toth, S., Robertson, C.E., Feazel, L.M., Rolle-Kampczyk, U., et al. (2013) Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity. Science, 339, 1084-1088. [Google Scholar] [CrossRef] [PubMed]
[10] Geuking, M.B., Koller, Y., Rupp, S. and McCoy, K.D. (2014) The Interplay between the Gut Microbiota and the Immune System. Gut Microbes, 5, 411-418. [Google Scholar] [CrossRef] [PubMed]
[11] McDermott, A.J. and Huffnagle, G.B. (2014) The Microbiome and Regulation of Mucosal Immunity. Immunology, 142, 24-31. [Google Scholar] [CrossRef] [PubMed]
[12] Paiardini, M. and Müller-Trutwin, M. (2013) HIV-Associated Chronic Immune Activation. Immunological Reviews, 254, 78-101. [Google Scholar] [CrossRef] [PubMed]
[13] Brenchley, J.M. (2004) CD4+ T Cell Depletion during All Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract. Journal of Experimental Medicine, 200, 749-759. [Google Scholar] [CrossRef] [PubMed]
[14] Dinh, D.M., Volpe, G.E., Duffalo, C., Bhalchandra, S., Tai, A.K., Kane, A.V., et al. (2014) The Intestinal Microbiota, Microbial Translocation and Systemic Inflammation in Chronic HIV Infection. The Journal of Infectious Diseases, 211, 19-27. [Google Scholar] [CrossRef] [PubMed]
[15] Kim, C.J., Nazli, A., Rojas, O.L., Chege, D., Alidina, Z., Huibner, S., et al. (2012) A Role for Mucosal IL-22 Production and Th22 Cells in HIV-Associated Mucosal Immunopathogenesis. Mucosal Immunology, 5, 670-680. [Google Scholar] [CrossRef] [PubMed]
[16] Brenchley, J.M., Paiardini, M., Knox, K.S., Asher, A.I., Cervasi, B., Asher, T.E., et al. (2008) Differential Th17 CD4 T-Cell Depletion in Pathogenic and Nonpathogenic Lentiviral Infections. Blood, 112, 2826-2835. [Google Scholar] [CrossRef] [PubMed]
[17] Brenchley, J.M., Price, D.A., Schacker, T.W., Asher, T.E., Silvestri, G., Rao, S., et al. (2006) Microbial Translocation Is a Cause of Systemic Immune Activation in Chronic HIV Infection. Nature Medicine, 12, 1365-1371. [Google Scholar] [CrossRef] [PubMed]
[18] Marchetti, G., Tincati, C. and Silvestri, G. (2013) Microbial Translocation in the Pathogenesis of HIV Infection and AIDS. Clinical Microbiology Reviews, 26, 2-18. [Google Scholar] [CrossRef] 
[19] Zevin, A.S., McKinnon, L., Burgener, A. and Klatt, N.R. (2016) Microbial Translocation and Microbiome Dysbiosis in HIV-Associated Immune Activation. Current Opinion in HIV and AIDS, 11, 182-190. [Google Scholar] [CrossRef] 
[20] Hsu, D.C. and Sereti, I. (2016) Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection. Drugs, 76, 533-549. [Google Scholar] [CrossRef] [PubMed]
[21] Moeller, A.H., Shilts, M., Li, Y., Rudicell, R.S., Lonsdorf, E.V., Pusey, A.E., Wilson, M.L., Hahn, B.H. and Ochman, H. (2013) SIV-Induced Instability of the Chimpanzee Gut Microbiome. Cell Host & Microbe, 14, 340-345. [Google Scholar] [CrossRef] [PubMed]
[22] Lozupone, C.A., Li, M., Campbell, T.B., Flores, S.C., Linderman, D., Gebert, M.J., Knight, R., Fontenot, A.P. and Palmer, B.E. (2013) Alterations in the Gut Microbiota Associated with HIV-1 Infection. Cell Host & Microbe, 14, 329-339. [Google Scholar] [CrossRef] [PubMed]
[23] Gori, A., Tincati, C., Rizzardini, G., Torti, C., Quirino, T., Haarman, M., et al. (2008) Early Impairment of Gut Function and Gut Flora Supporting a Role for Alteration of Gastrointestinal Mucosa in Human Immunodeficiency Virus Pathogenesis. Journal of Clinical Microbiology, 46, 757-758. [Google Scholar] [CrossRef] 
[24] Ellis, C.L., Ma, Z.M., Mann, S.K., Li, C.S., Wu, J., Knight, T.H., et al. (2011) Molecular Characterization of Stool Microbiota in HIV-Infected Subjects by Panbacterial and Order-Level 16S Ribosomal DNA (rDNA) Quantification and Correlations with Immune Activation. JAIDS Journal of Acquired Immune Deficiency Syndromes, 57, 363-370. [Google Scholar] [CrossRef] 
[25] Zilberman-Schapira, G., Zmora, N., Itav, S., Bashiardes, S., Elinav, H. and Elinav, E. (2016) The Gut Microbiome in Human Immunodeficiency Virus Infection. BMC Medicine, 14, 83. [Google Scholar] [CrossRef] [PubMed]
[26] Dillon, S.M., Lee, E.J., Kotter, C.V., Austin, G.L., Dong, Z., Hecht, D.K., et al. (2014) An Altered Intestinal Mucosal Microbiome in HIV-1 Infection Is Associated with Mucosal and Systemic Immune Activation and Endotoxemia. Mucosal Immunology, 7, 983-994. [Google Scholar] [CrossRef] [PubMed]
[27] Mutlu, E.A., Keshavarzian, A., Losurdo, J., Swanson, G., Siewe, B., Forsyth, C., et al. (2014) A Compositional Look at the Human Gastrointestinal Microbiome and Immune Activation Parameters in HIV Infected Subjects. PLOS Pathogens, 10, e1003829. [Google Scholar] [CrossRef] [PubMed]
[28] Sun, Y., Ma, Y., Lin, P., Tang, Y.W., Yang, L., Shen, Y., et al. (2016) Fecal Bacterial Microbiome Diversity in Chronic HIV-Infected Patients in China. Emerging Microbes & Infections, 5, e31. [Google Scholar] [CrossRef] [PubMed]
[29] Yang, L., Poles, M.A., Fisch, G.S., Ma, Y., Nossa, C., Phelan, J.A., et al. (2016) HIV-Induced Immunosuppression Is Associated with Colonization of the Proximal Gut by Environmental Bacteria. AIDS, 30, 19-29. [Google Scholar] [CrossRef] 
[30] Dillon, S.M., Lee, E.J., Kotter, C.V., Austin, G.L., Gianella, S., Siewe, B., et al. (2016) Gut Dendritic Cell Activation Links an Altered Colonic Microbiome to Mucosal and Systemic T-Cell Activation in Untreated HIV-1 Infection. Mucosal Immunology, 9, 24-37. [Google Scholar] [CrossRef] [PubMed]
[31] Perez-Santiago, J., Gianella, S., Massanella, M., Spina, C.A., Karris, M.Y., Var, S.R., et al. (2013) Gut Lactobacillales Are Associated with Higher CD4 and Less Microbial Translocation during HIV Infection. AIDS, 27, 1921-1931. [Google Scholar] [CrossRef] 
[32] Nowak, P., Troseid, M., Avershina, E., Barqasho, B., Neogi, U., Holm, K., et al. (2015) Gut Microbiota Diversity Predicts Immune Status in HIV-1 Infection. AIDS, 29, 2409-2418. [Google Scholar] [CrossRef] 
[33] Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J. and Brummer, R.J. (2008) Review Article: The Role of Butyrate on Colonic Function. Alimentary Pharmacology & Therapeutics, 27, 104-119. [Google Scholar] [CrossRef] [PubMed]
[34] Macfarlane, S. and Macfarlane, G.T. (2003) Regulation of Short-Chain Fatty Acid Production. Proceedings of the Nutrition Society, 62, 67-72. [Google Scholar] [CrossRef] 
[35] Louis, P. and Flint, H.J. (2009) Diversity, Metabolism and Microbial Ecology of Butyrate-Producing Bacteria from the Human Large Intestine. FEMS Microbiology Letters, 294, 1-8. [Google Scholar] [CrossRef] [PubMed]
[36] McHardy, I.H., Li, X., Tong, M., Ruegger, P., Jacobs, J., Borneman, J., et al. (2013) HIV Infection Is Associated with Compositional and Functional Shifts in the Rectal Mucosal Microbiota. Microbiome, 1, 26. [Google Scholar] [CrossRef] [PubMed]
[37] Monaco, C.L., Gootenberg, D.B., Zhao, G., Handley, S.A., Ghebremichael, M.S., Lim, E.S., et al. (2016) Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome. Cell Host Microbe, 19, 311-322. [Google Scholar] [CrossRef] [PubMed]
[38] Troy, E.B. and Kasper, D.L. (2010) Beneficial Effects of Bacteroides fragilis Polysaccharides on the Immune System. Frontiers in Bioscience (Landmark Ed), 15, 25-34. [Google Scholar] [CrossRef] [PubMed]
[39] Noguera-Julian, M., Rocafort, M., Guillén, Y., Rivera, J., Casadellà, M., Nowak, P., et al. (2016) Gut Microbiota Linked to Sexual Preference and HIV Infection. EBioMedicine, 5, 135-146. [Google Scholar] [CrossRef] [PubMed]
[40] Vazquez-Castellanos, J.F., Serrano-Villar, S., Latorre, A., Artacho, A., Ferrus, M.L., Madrid, N., et al. (2014) Altered Metabolism of Gut Microbiota Contributes to Chronic Immune Activation in HIV-Infected Individuals. Mucosal Immunology, 8, 760-772. [Google Scholar] [CrossRef] [PubMed]
[41] Vujkovic-Cvijin, I., Dunham, R.M., Iwai, S., Maher, M.C., Albright, R.G., Broadhurst, M.J., et al. (2013) Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism. Science Translational Medicine, 5, 193ra191. [Google Scholar] [CrossRef] [PubMed]
[42] Paquin-Proulx, D., Ching, C., Vujkovic-Cvijin, I., Fadrosh, D., Loh, L., Huang, Y., et al. (2016) Bacteroides Are Associated with GALT iNKT Cell Function and Reduction of Microbial Translocation in HIV-1 Infection. Mucosal Immunology, 10, 69-78. [Google Scholar] [CrossRef] [PubMed]
[43] Favre, D., Mold, J., Hunt, P.W., Kanwar, B., Loke, P., Seu, L., et al. (2010) Tryptophan Catabolism by Indoleamine 2, 3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease. Science Translational Medicine, 2, 32ra36. [Google Scholar] [CrossRef] [PubMed]
[44] Brown, J.M. and Hazen, S.L. (2015) The Gut Microbial Endocrine Organ: Bacterially Derived Signals Driving Cardiometabolic Diseases. Annual Review of Medicine, 66, 343-359. [Google Scholar] [CrossRef] [PubMed]
[45] Romano, K.A., Vivas, E.I., Amador-Noguez, D. and Rey, F.E. (2015) Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide. MBio, 6, e02481. [Google Scholar] [CrossRef] 
[46] Tang, W.H. and Hazen, S.L. (2014) The Contributory Role of Gut Microbiota in Cardiovascular Disease. Journal of Clinical Investigation, 124, 4204-4211. [Google Scholar] [CrossRef] 
[47] Haissman, J.M., Knudsen, A., Hoel, H., Kjaer, A., Kristoffersen, U.S., Berge, R.K., et al. (2016) Microbiota-Dependent Marker TMAO Is Elevated in Silent Ischemia But Is Not Associated with First-Time Myocardial Infarction in HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes, 71, 130-136. [Google Scholar] [CrossRef] 
[48] Knudsen, A., Christensen, T.E., Thorsteinsson, K., Ghotbi, A.A., Hasbak, P., Lebech, A.M., et al. (2016) Microbiota-Dependent Marker TMAO Is Not Associated With Decreased Myocardial Perfusion in Well-Treated HIV-Infected Patients as Assessed by 82Rubidium PET/CT. JAIDS Journal of Acquired Immune Deficiency Syndromes, 72, e83-e85. [Google Scholar] [CrossRef] 
[49] Miller, P.E., Haberlen, S.A., Brown, T.T., Margolick, J.B., DiDonato, J.A., Hazen, S.L., et al. (2016) Brief Report: Intestinal Microbiota-Produced Trimethylamine-N-Oxide and Its Association with Coronary Stenosis and HIV Serostatus. JAIDS Journal of Acquired Immune Deficiency Syndromes, 72, 114-118. [Google Scholar] [CrossRef] 
[50] Srinivasa, S., Fitch, K.V., Lo, J., Kadar, H., Knight, R., Wong, K., et al. (2015) Plaque Burden in HIV-Infected Patients Is Associated with Serum Intestinal Microbiota-Generated Trimethylamine. AIDS, 29, 443-452. [Google Scholar] [CrossRef] 
[51] Serrano-Villar, S., Rojo, D., Martinez-Martinez, M., Deusch, S., Vazquez-Castellanos, J.F., Sainz, T., et al. (2016) HIV Infection Results in Metabolic Alterations in the Gut Microbiota Different from Those Induced by Other Diseases. Scientific Reports, 6, 26192. [Google Scholar] [CrossRef] [PubMed]

为你推荐